Related Experiment Video
Updated: May 14, 2026
05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
An expanded prescribing role for pharmacists - an Australian perspective
Kreshnik Hoti1, Jeffery Hughes, Bruce Sunderland
1Curtin Health and Innovation Research Institute, School of Pharmacy, Curtin University, Perth, WA, Australia.
The Australasian Medical Journal
|February 9, 2013
Summary
Australian pharmacists and consumers support expanding prescribing roles beyond over-the-counter medications. Key considerations include training and improved patient medication access, with doctors maintaining diagnostic primacy.
Area of Science:
- Pharmacy Practice
- Pharmacology
- Health Policy
Background:
- Pharmacist prescribing in Australia is currently restricted to over-the-counter medications.
- Expanded pharmacist prescribing represents a novel professional practice area.
- International models of expanded prescribing exist, providing context for Australian implementation.
Purpose of the Study:
- To identify and review Australian studies on expanded pharmacist prescribing.
- To analyze Australian research within the global context of pharmacist prescribing.
- To synthesize findings on attitudes and key issues related to expanded pharmacist prescribing in Australia.
Main Methods:
- A literature review of Australian studies was conducted.
- Studies focused on pharmacist prescribing were identified and analyzed.
- Both healthcare professional and consumer perspectives were considered.
Main Results:
- Australian pharmacists and pharmacy clients show support for expanded prescribing roles.
- A consensus exists regarding the need for additional pharmacist training.
- Improved medication access for patients is a key anticipated benefit.
- Consumers prefer physicians retain the primary diagnostic role.
Conclusions:
- Evidence from Australian studies supports moving forward with expanded pharmacist prescribing.
- Policymakers can utilize current research to inform decision-making.
- Addressing training needs and defining the scope of practice are crucial for successful implementation.
Related Concept Videos
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:02Prescription, Nonprescription and Orphan Drugs
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
01:03Drug Control Governance: Regulatory Bodies and Their Impact
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...